This healthcare company just announced the signing of a contract with Optica Central, the third largest optical chain store in Costa Rica for implementation of CARA across Costa Rica. Diagnos Inc. (OTCQB:DGNOF) saw its shares pop following the headline.
Diagnos is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, U.S., UAE, Saudi Arabia and others. The company's key revenue is derived from Canada.
Traders were excited on the news as they grabbed up shares to a session high of $0.4795/share (+9.22%) following the news. This move appears to be a bullish breakout following the pullback experienced since the 52-week high made in January of this year.
